What is Ranfac?
Headquartered in Avon, Massachusetts, Ranfac operates as a high-mix, single-source manufacturer dedicated to the design and production of Class I and II medical devices. The company distinguishes itself through a comprehensive service model that spans the entire product lifecycle, from initial conceptualization to final market delivery. By focusing on specialized applications within the orthobiologics, minimally invasive surgery, and hematology sectors, Ranfac provides integrated manufacturing solutions that prioritize quality and strict regulatory compliance. Their state-of-the-art facility serves as a hub for innovation, allowing the firm to address the nuanced requirements of its diverse client base with agility and technical expertise.
How much funding has Ranfac raised?
Ranfac has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Ranfac
PPP
Public-Private Partnership
What's next for Ranfac?
With this major enterprise-level funding, Ranfac is poised to accelerate its strategic growth initiatives and enhance its manufacturing infrastructure. The capital injection will likely be directed toward scaling production capacity to meet the rising demand for minimally invasive surgical tools and advanced orthobiologic devices. As the company continues to refine its development processes, the focus will remain on maintaining high standards of quality assurance while exploring new market opportunities. By leveraging its proven track record and technical proficiency, Ranfac aims to solidify its position as a preferred partner for medical device innovation, ensuring that it remains at the forefront of clinical advancements and patient-centric manufacturing.
See full Ranfac company page
